Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients

Clinical trial NCT02825420 · COMPLETED

Trial details

NCT number: NCT02825420
Sponsor: PharmaMar
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsed Ovarian Cancer

Start date: 2015-07-28
Primary completion: 2019-09-18
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.